Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 18:07 (1328 d 22:27 ago) – Posting: # 21893
Views: 7,367

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?

Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
22,985 posts in 4,823 threads, 1,653 registered users;
54 visitors (0 registered, 54 guests [including 6 identified bots]).
Forum time: 16:34 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5